TAILIEUCHUNG - Bài giảng Hepatitis B Reactivation: A Largely Preventable Problem

Bài giảng “Hepatitis B Reactivation: A Largely Preventable Problem” giới thiệu tới người đọc các kiến thức: Users are encouraged to use these slides in their own noncommercial presentations, but we ask that content and attribution not be changed. Users are asked to honor this intent; these slides may not be published or posted online without permission from Clinical Care Options. nội dung chi tiết. | CLINICAL CARE OPTIONS HEPATITIS Hepatitis B Reactivation A Largely Preventable Problem Jordan J. Feld MD MPH Assistant Professor of Medicine University of Toronto Hepatologist Toronto Western Hospital Liver Centre McLaughlin-Rotman Centre for Global Health Toronto Ontario Canada This program is supported by an educational grant from Ú GILEAD Advancing Therapeutics. Improving Lives. Hepatitis B Reactivation A Largely Preventable Problem hepatitis I EQ CLINICAL CARE OPTIONS HEPATITIS About These Slides Users are encouraged to use these slides in their own noncommercial presentations but we ask that content and attribution not be changed. Users are asked to honor this intent These slides may not be published or posted online without permission from Clinical Care Options email permissions@ Disclaimer The materials published on the Clinical Care Options Web site reflect the views of the authors of the CCO material not those of Clinical Care Options LLC the CME providers or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials. Hepatitis B Reactivation A Largely Preventable Problem hepatitis CLINICAL CARE OPTIONS Faculty Disclosures Jordan J. Feld MD MPH has disclosed that he has received consulting fees from Gilead .

• Y khoa - Dược
• Hepatitis B Reactivation
• A Largely Preventable Problem
• Faculty Disclosures
• Clinical Care Options
• HBV Reactivation
• Rate of HBV Reactivation
• BMC Musculoskeletal Disorders
• Rheumatoid arthritis
• Hepatitis B virus
• Disease modifying antirheumatic drugs
• Logistic regression analyses
• BMC Pharmacology and Toxicology
• Hepatitis B
• Disease modifying anti rheumatic drugs
• Hepatitis virus